Larimar Therapeutics
LRMR
#7066
Rank
A$0.60 B
Marketcap
$9.47
Share price
0.49%
Change (1 day)
87.12%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.39

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.41. In 2022 the company made an earnings per share (EPS) of -$2.37 an increase over its 2021 EPS that were of -$4.57.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.39-41.42%
2022-$2.37-48.15%
2021-$4.57-14.27%
2020-$5.33